Eurointervention

Papers
(The H4-Index of Eurointervention is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
In search of the origin of the acronym TAVI258
TAVR under 70: is age just a number?141
International variation in modality and outcomes of left main revascularisation: does it really matter?117
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity113
Double-tap to treat paravalvular leak in high-risk annuli105
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study86
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis83
Transcatheter left ventriculoplasty76
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis66
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement59
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s58
Recanalisation of coronary chronic total occlusions53
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry51
Defer-based non-stenting: a promising approach for STEMI48
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure47
Hybrid coronary revascularisation: the best or the worst of both worlds?44
The “road travelled”: reflections on the transformation of information exchange in a digital age43
   Atrial fibrillation and acute coronary syndrome 43
One-month DAPT after acute coronary syndrome: too short or not too short?40
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study37
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve37
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document36
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection36
Redo transcatheter mitral valve replacement in mitral annular calcification35
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation35
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis34
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study34
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes34
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial33
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study32
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD31
Geographical variations in left main coronary artery revascularisation: a prespecified analysis of the EXCEL trial31
0.063874959945679